Electronic Real-Time Heart Team Decision-making vs. Usual Care in Patients With Triple-Vessel Coronary Artery Disease and Diabetes Mellitus
NCT ID: NCT07326514
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
1350 participants
INTERVENTIONAL
2026-01-01
2028-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease
NCT05595226
coRonary assEssment of Preoperative vaLvulopathy pAtients Using ComputEd Tomographic Angiography (REPLACE)
NCT02632617
China PEACE-Prospective 3-vessel Disease Study
NCT01625312
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
NCT07267117
Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in "Real World" Chinese Patients
NCT06257043
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Real-time heart team group
A online multidisciplinary heart team discussion and decision-making will be conducted during angiography
Real-Time Heart Team Decision-making
A online multidisciplinary heart team discussion and decision-making will be conducted during coronary angiography.
Usual care group
An usual care decision-making initiated by interventional cardiologists will be conducted
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Real-Time Heart Team Decision-making
A online multidisciplinary heart team discussion and decision-making will be conducted during coronary angiography.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diabetes mellitus;
3. Three-vessel coronary artery disease (≥70% stenosis in the left anterior descending artery, circumflex artery, and right coronary artery system);
4. Patients who required heart team discussion judging by the interventional cardiologist.
Exclusion Criteria
2. Acute myocardial infarction with ECG and biomarker tests indicating acute phase;
3. Concurrent severe valvular heart disease, large vessel disease, or giant ventricular aneurysm requiring surgical intervention;
4. Concurrent atrial fibrillation or severe arrhythmia;
5. Other emergency admissions where elective revascularization is contraindicated;
6. Refusal or rejection of a specific treatment options (PCI or CABG);
7. Refusal to participate in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese Academy of Medical Sciences, Fuwai Hospital
OTHER
The First Affiliated Hospital of Dalian Medical University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Fuwai Yunnan Cardiovascular Hospital
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
Central China Fuwai Hospital of Zhengzhou University
OTHER
Ruijin Hospital
OTHER
Nanjing First Hospital, Nanjing Medical University
OTHER
Shenzhen Sun Yat-sen Cardiovascular Hospital
OTHER
China National Center for Cardiovascular Diseases
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-2850
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.